Silexion Therapeutics Corp Share Price Today: Live Updates & Key Insights

Silexion Therapeutics Corp share price today is $1.25, up -15.21%. The stock opened at $1.4 against the previous close of $1.4388, with an intraday high of $1.4 and low of $1.24.

Silexion Therapeutics Corp Share Price Chart

Silexion Therapeutics Corp

us-stock
To Invest in {{usstockname}}
us-stock

Silexion Therapeutics Corp Share Price Performance

$1.25 -0.1521(-15.21%) SLXN at 23 Mar 2026 03:15 PM Biotechnology
Lowest Today 1.24
Highest Today 1.4
Today’s Open 1.4
Prev. Close 1.4388
52 Week High 22.36
52 Week Low 1.21
Day’s Range: Low 1.24 High 1.4
52-Week Range: Low 1.21 High 22.36
1 day return -
1 Week return -22.64
1 month return -20.12
3 month return -50.6
6 month return -66.11
1 year return +7.89
3 year return -
5 year return -
10 year return -

Silexion Therapeutics Corp Institutional Holdings

Silexion Therapeutics Corp Market Status

Strong Buy: 0

Buy: 1

Hold: 0

Sell: 0

Strong Sell: 0

Silexion Therapeutics Corp Fundamentals

Market Cap 5.20 M

PB Ratio 0.6869

PE Ratio 0.0045

Enterprise Value -2.43 M

Total Assets 7.22 M

Volume 63535

Silexion Therapeutics Corp Company Financials

About Silexion Therapeutics Corp & investment objective

Company Information Silexion Therapeutics Corp, a biopharmaceutical company, discovers and develops RNA interference (RNAi)-based cancer drugs and delivery systems to treat malignant solid tumors. The company engages in the treatment of solid tumors through its proprietary LODER delivery platform. Its products comprise SiG12D-LODER that has completed pre-clinical studies and an open label Phase I clinical trial for the treatment of pancreatic cancer; Prostate-LODER, which is in pre-clinical studies for the treatment of prostate cancer; and GBM-LODER that is in pre-clinical studies to target Glioblastoma Multiform, a malignant primary brain tumor. Silexion Therapeutics Corp has collaboration with Evonik Corporation for the development of an advanced siRNA formulation to enhance cancer treatment. The company was founded in 2008 and is headquartered in Jerusalem, Israel.

Organisation Biotechnology

Employees 11

Industry Biotechnology

CEO Mr. Ilan Hadar M.B.A.

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

Silexion Therapeutics Corp FAQs

What is the share price of Silexion Therapeutics Corp today?

The current share price of Silexion Therapeutics Corp is $1.25.

Can I buy Silexion Therapeutics Corp shares in India?

Yes, Indian investors can buy Silexion Therapeutics Corp shares by opening an international trading and demat account with Motilal Oswal.

How to buy Silexion Therapeutics Corp shares in India?

You can easily invest in Silexion Therapeutics Corp shares from India by:

Can I buy fractional shares of Silexion Therapeutics Corp?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Silexion Therapeutics Corp?

Silexion Therapeutics Corp has a market cap of $5.20 M.

In which sector does Silexion Therapeutics Corp belong?

Silexion Therapeutics Corp operates in the Biotechnology sector.

What documents are required to invest in Silexion Therapeutics Corp stocks?

To invest, you typically need:

What is the PE and PB ratio of Silexion Therapeutics Corp?

The PE ratio of Silexion Therapeutics Corp is 0.00 and the PB ratio is 0.69.